Russell J. Cox, EVP & Chief Commercial Officer at Jazz Pharmaceuticals plc (JAZZ), sold 4,000 shares at $166.12 ($658K) on 2014-02-27, disclosed to the SEC on 2014-03-03.
Open-market sale of $658k JAZZ by EVP & Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $160.00 | 1,000 | $160K | 24.3% |
| 2 | $166.12 | 3,000 | $498K | 75.7% |
| Total | $164.59 avg | 4,000 | $658K | 100% |
| Filing → |
| JAZZ | SELL | 2017-01-19 | $515K | — | Filing → |
| JAZZ | SELL | 2016-08-10 | $595K | — | Filing → |
| JAZZ | SELL | 2016-04-13 | $548K | — | Filing → |